Rare disease news, mapped to the diseases behind the headlines. AI-classified across pipeline, policy, funding, science, and community.
Be among the first to receive Kisho Intelligence Briefings
Showing news related to
Showing 1–3 of 3 stories
Argo Biopharma has initiated a phase 2b trial of its siRNA therapeutic BW-20829, targeting patients with elevated lipoprotein(a) levels. This global study marks a significant step in addressing cardiovascular risks associated with Lp(a).
The Million Hearts initiative encourages gift-giving that promotes heart health this holiday season. This campaign aims to raise awareness about cardiovascular disease prevention.
A recent CDC report indicates that cardiovascular disease rates are decreasing among adults with diabetes, highlighting improved health management. Additionally, there is a noted increase in the frequency of blood sugar monitoring among this population.
Get the week's most important rare disease developments — pipeline moves, policy changes, and funding signals — delivered to your inbox every Monday.
Free weekly briefing. Unsubscribe anytime.